Learn about Arbutus's promising Hepatitis B treatments, strong financial position, and projections for the global market.

The current standard of care for HCV is a combination of PEGylated–interferon (PEG–IFN) and ribavirin. PEG-IFNs available on the market include PEG–Intron (Schering–Plough) and Pegasys ...

Janssen HLA et al. (2005) Pegylated interferon α-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365: 123–129 Janssen and ...

Oral Presentations The Company will present its lead asset, PP-007 (PEGylated carboxyhemoglobin bovine, also known as SANGUINATE ®), a novel clinical stage biopharmaceutical product that is ...

Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome.